
In a Q&A, 2 ophthalmologists provide an overview and offer some perspective on the risks and heritability associated with glaucoma.

In a Q&A, 2 ophthalmologists provide an overview and offer some perspective on the risks and heritability associated with glaucoma.

Researchers find a significant benefit at day 28 when compared to a group taking a placebo.

The 3D-printed implant is patient specific and modeled after the anatomy of the individual.

Partnerships between primary care physicians and pulmonologists may improve vaccination rates for patients with COPD.

The number of individuals suffering from vision impairment expected to rise to 895 million by 2050.

Vitamin D supplements did not change the biochemical markers significantly for hepatitis C patients with vitamin D insufficiencies.

The monoclonal antibody may provide a novel treatment pathway for the chronic, often deadly pulmonary disease.

Uncovering the zoological host that first transmitted the virus to humans could inform factors relevant to this pandemic—and the next one.

The suspension is due to recently reported diagnoses of AML and myelodysplastic syndrome in 2 treated patients.

The approval was based on data from the PARAGON-HF study.

The investigators found the primary efficacy endpoints occurred in 20 evaluable patients (87%).

Dr. Khan discusses some of the risk factors associated with CHD.

No approved treatment for leber hereditary optic neuropathy is currently available in the United States.

Phase 3 COMET findings show the Sanofi Genzyme product delivered significantly improved efficacy and safety for the rare autosomal disorder.

The FDA gives Moderna the green light to increase vaccine vials by 40%.

In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations.

Researchers find higher neurocognitive abilities are associated with an improvement of everyday life.

A Stanford Cardiovascular Institute expert details a recent review into managing a growing field of agents.

Obese individuals were found to have a higher odds ratio of developing IIH compared to non-obese people.

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

Researchers found a stable pattern of behavioral inhibition from toddlerhood to childhood predicted greater worry dysregulation in adolescence.

Investigators conclude improvements in kidney transplantation may require significant interventions.

The company plans to submit the data to the FDA and EMA for consideration of the injectable bispecific antibody's regulatory approval for the treatment of both conditions.

A recent study reports that obese patients experienced high immunogenicity compared with those of normal weight.

Researchers find an increased risk of offspring ADHD symptoms due to maternal anxiety.

The new study underscores the importance of annual urine analysis to catch signs of diabetic nephropathy.

The indication is the first granted to an ANGPTL3 inhibitor in the US.

Researchers believe identifying more risk factors could be beneficial in reducing cardiovascular disease.

The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.

In results from a phase 2 trial show 7.5gm of DAV132 administered three times daily demonstrated protection against antibiotic-induced disruption of intestinal microbiota.